EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Iron chelation therapy for children with transfusion‐dependent β‐thalassemia: How young is too young?

Gian Luca Forni iD, Antonis Kattamis, Kevin H M Kuo iD, Aurelio Maggio, Sujit Sheth, Ali T Taher iD, Vip Viprakasit iD

Pediatric Blood & Cancer · 2024-08 · 71 (8)

DOI: 10.1002/pbc.31035 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 16.05.2024. Verfasst von Gian Luca Forni und 6 weiteren Autor:innen. Beteiligte Einrichtung: ForAnemia Foundation, Genoa, Italy. Hauptthemen laut MEDLINE: beta-Thalassemia, Iron Chelating Agents, Iron Overload, Chelation Therapy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Pharmacosmos.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this review, we provide a summary of evidence on iron overload in young children with transfusion‐dependent β‐thalassemia (TDT) and explore the ideal timing for intervention. Key data from clinical trials and observational studies of the three available iron chelators deferoxamine, deferiprone, and deferasirox are also evaluated for inclusion of subsets of young children, especially those less than 6 years of age. Evidence on the efficacy and safety of iron chelation therapy for children ≥2 years of age with transfusional iron overload is widely available. New data exploring the risks and benefits of early‐start iron chelation in younger patients with minimal iron overload are also emerging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-ThalassemiaIron Chelating AgentsIron OverloadChelation TherapyBlood TransfusionHumansChildChild, PreschoolDeferoxamineDeferipronePyridones

Stichwörter der Autor:innen

ferritinheartiron chelationiron overloadliverthalassemia

Substanzen

Iron Chelating AgentsDeferoxamineDeferipronePyridones

Autor:innen und Institutionen

  • ForAnemia Foundation, Genoa, Italy.
  • First Department of Pediatrics, National and Kapodistrian University of Athens, Athens, Greece.
  • Division of Hematology, University of Toronto, Toronto, Ontario, Canada.
  • Campus of Haematology Franco and Piera Cutino, AOOR Villa Sofia-V. Cervello, Palermo, Italy.
  • Division of Hematology and Oncology, Department of Pediatrics, Weill Cornell Medicine, New York, New York, USA.
  • Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.

ORCID-Profile: Gian Luca Forni, Kevin H M Kuo, Ali T Taher, Vip Viprakasit

Förderung

  • Pharmacosmos

Zitieren

APA

Forni, G. L., Kattamis, A., Kuo, K. H. M., Maggio, A., Sheth, S., Taher, A. T., & Viprakasit, V. (2024). Iron chelation therapy for children with transfusion‐dependent β‐thalassemia: How young is too young?. Pediatric Blood & Cancer, 71(8). https://doi.org/10.1002/pbc.31035

Vancouver

Forni GL, Kattamis A, Kuo KHM, Maggio A, Sheth S, Taher AT, et al. Iron chelation therapy for children with transfusion‐dependent β‐thalassemia: How young is too young?. Pediatric Blood & Cancer. 2024;71(8). doi:10.1002/pbc.31035

BibTeX
@article{Forni2024,
  author = {Forni, Gian Luca and Kattamis, Antonis and Kuo, Kevin H M and Maggio, Aurelio and Sheth, Sujit and Taher, Ali T and Viprakasit, Vip},
  title = {Iron chelation therapy for children with transfusion‐dependent β‐thalassemia: How young is too young?},
  journal = {Pediatric Blood & Cancer},
  year = {2024},
  volume = {71},
  number = {8},
  doi = {10.1002/pbc.31035}
}
Kostenlos starten →